Polaris Genomics: Funding, Investors & Team (Sep 2026)
Polaris Genomics is utilizing molecular biomarkers to advance mental health diagnostics and novel therapeutics. The company identifies genomic biomarkers to aid in the development of psychiatric drugs and tools. Their ADAPT Platform™ compiles information on gene network pathways relevant to various neuropsychiatric conditions, such as anxiety, depression, and PTSD, through a targeted neuropsychiatric gene panel, deep analytics engine, and data repository. Specifically, ADAPT has successfully identified transcriptomic biomarkers for PTSD and introduced the PTS-ID™ clinical blood test for PTSD screening.
Polaris Genomics has raised $2.3M across 3 funding rounds on record, the most recent an undisclosed round of $250k announced in Aug 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Polaris Genomics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Polaris Genomics Funding Rounds
Polaris Genomics raised $1.0M in an undisclosed round announced in May 2023.
7 months later, an undisclosed round of $1.0M was announced in Dec 2023.
1.7 years later, an undisclosed round of $250k was announced in Aug 2025.
Polaris Genomics Founders and Leadership Team
Contact details for the Polaris Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →Polaris Genomics Funding Compared to Other Biotechnology Startups
Polaris Genomics' latest round of $250k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Polaris Genomics in Biotechnology and Gaithersburg
Companies Similar to Polaris Genomics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Polaris Genomics Funding FAQs
What does Polaris Genomics do?
Polaris Genomics is utilizing molecular biomarkers to advance mental health diagnostics and novel therapeutics. The company identifies genomic biomarkers to aid in the development of psychiatric drugs and tools. Their ADAPT Platform™ compiles information on gene network pathways relevant to various neuropsychiatric conditions, such as anxiety, depression, and PTSD, through a targeted neuropsychiatric gene panel, deep analytics engine, and data repository. Specifically, ADAPT has successfully identified transcriptomic biomarkers for PTSD and introduced the PTS-ID™ clinical blood test for PTSD screening.
How much funding has Polaris Genomics raised?
Polaris Genomics has raised $2.3M across 3 rounds on record. The most recent is an undisclosed round of $250k announced in Aug 2025.
When did Polaris Genomics last raise funding?
Polaris Genomics' most recent funding round on record is an undisclosed round of $250k, announced in Aug 2025.
Who is the CEO of Polaris Genomics?
Charles Cathlin is listed as CEO at Polaris Genomics.
Where is Polaris Genomics headquartered?
Polaris Genomics is based in Gaithersburg, Maryland, United States.
How many employees does Polaris Genomics have?
Polaris Genomics is in the 11-50 employee band.
How does Polaris Genomics' funding compare to other Biotechnology startups?
Polaris Genomics' latest round of $250k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Polaris Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Polaris Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.